Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2021 Jan 21;21(1):36.
doi: 10.1186/s12890-021-01410-z.

Role of IL-22 in persistent allergic airway diseases caused by house dust mite: a pilot study

Laura Tamasauskiene  1 , Vilte Marija Gintauskiene  2 , Daina Bastyte  2 , Brigita Sitkauskiene  2
Affiliations

Role of IL-22 in persistent allergic airway diseases caused by house dust mite: a pilot study

Laura Tamasauskiene et al. BMC Pulm Med. .

Abstract

Background: Persistent allergic airway diseases cause a great burden worldwide. Their pathogenesis is not clear enough. There is evidence that one of the recently described cytokine interleukin (IL) 22 may be involved in the pathogenesis of these diseases. Scientists argue if this cytokine acts as proinflammatory or anti-inflammatory agent. The aim of this study was to investigate IL-22 level in patients with persistent allergic airway diseases caused by house dust mite (HDM) in comparison with healthy individuals and to evaluate its relationship with IL-13 and IL-10 level, symptoms score and quality of life.

Methods: Patients with persistent allergic rhinitis caused by HDM and having symptoms for at least 2 years with or without allergic asthma were involved into the study. Measurements of IL-22, IL-13 and IL-10 and in serum and nasal lavage was performed by ELISA. Questionnaires assessing symptoms severity and quality of life were used.

Results: A tendency was observed that IL-22 in serum and nasal lavage was higher in patients with allergic airway diseases compared to control group (14.86 pg/ml vs. 7.04 pg/ml and 2.67 pg/ml vs. 1.28 pg/ml, respectively). Positive statistically significant correlation was estimated between serum IL-22 and serum IL-10 (rs = 0.57, p < 0.01) and IL-13 (rs = 0.44, p < 0.05) level. Moreover, positive significant correlation was found between IL-22 in nasal lavage and IL-10 in nasal lavage (rs = 0.37, p < 0.05). There was a negative statistically significant correlation between serum IL-22 and Rhinoconjunctivitis Quality of Life Questionnaire (RQLQ) (rs = - 0.42, p < 0.05).

Conclusion: Our study showed a possible anti-inflammatory effect of IL-22 in patients with persistent allergic airway diseases caused by HDM.

Keywords: Allergic asthma; Allergic rhinitis; House dust mite; IL-22; Persistent allergic airway diseases.

PubMed Disclaimer

Conflict of interest statement

The authors declare that they have no competing interests.

Figures

Fig. 1
Fig. 1
IL-22, IL-10 and IL-13 level in serum and nasal lavage in patients with allergic airway diseases and healthy individuals
Fig. 2
Fig. 2
Spearman’s correlation between IL-22, IL-10 and IL-13 in serum and nasal lavage in patients with allergic airway diseases. a rs = 0.44, p < 0.05, b rs = 0.57, p < 0.01, c rs = 0.1, p > 0.05, d rs = 0.37, p < 0.05
See this image and copyright information in PMC

Similar articles

See all similar articles

Cited by

References

    1. Asthma GI for. Global strategy for asthma management and prevention. 2020.
    1. Blaiss MS, Hammerby E, Robinson S, Kennedy-Martin T, Buchs S. The burden of allergic rhinitis and allergic rhinoconjunctivitis on adolescents: a literature review. Ann Allergy Asthma Immunol. 2018;121(1):43–52.e3. doi: 10.1016/j.anai.2018.03.028. - DOI - PubMed
    1. Meltzer EO. Allergic rhinitis: burden of illness, quality of life, comorbidities, and control. Immunol Allergy Clin North Am. 2016;36(2):235–248. doi: 10.1016/j.iac.2015.12.002. - DOI - PubMed
    1. Lee LK, Obi E, Paknis B, Kavati A, Chipps B. Asthma control and disease burden in patients with asthma and allergic comorbidities. J Asthma. 2018;55(2):208–219. doi: 10.1080/02770903.2017.1316394. - DOI - PubMed
    1. Broek JL, Bousquet J, Baena-Cagnani CE, Bonini S, Canonica GW, Casale TB, et al. Allergic Rhinitis and its Impact on Asthma (ARIA) guidelines: 2010 Revision. J Allergy Clin Immunol. 2010;126(3):466–476. doi: 10.1016/j.jaci.2010.06.047. - DOI - PubMed